Machine Learning for the Identification of a Common Signature for Anti–SSA/Ro 60 Antibody Expression Across Autoimmune Diseases

Anti‐Ro autoantibodies are among the most frequently detected extractable nuclear antigen autoantibodies, mainly associated with primary Sjögren's syndrome (SS), systemic lupus erythematosus (SLE), and undifferentiated connective tissue disease (UCTD). This study was undertaken to determine if there is a common signature for all patients expressing anti–Ro 60 autoantibodies regardless of their disease phenotype.

M. Alarcón‐Riquelme | M. González-Gay | N. Barbarroja | J. Pers | A. Saraux | V. Devauchelle-Pensec | L. Kovács | G. Espinosa | Marcus John Beasley | F. Hiepe | L. Beretta | C. Jamin | C. Le Dantec | S. Jousse-Joulin | J. Cremer | E. de Ramón | T. Witte | D. Cornec | C. Chizzolini | M. Hernandez-Fuentes | N. Hunzelmann | M. Brandão | F. Farinha | G. Stummvoll | N. Ortego | Q. Cheng | B. Lauwerys | C. Vasconcelos | C. López-Pedrera | R. Ortega-Castro | L. Khodadadi | R. Lories | M. Gerosa | T. Schioppo | Pierre-Emmanuel Jouve | R. Aguilar-Quesada | M. Zauner | S. Dulić | B. Rouvière | Y. Ioannou | E. De Langhe | Tianlu Li | K. Kniesch | Éléonore Bettacchioli | A. Balog | Z. Makowska | A. Buttgereit | C. Marañón | N. Varela | I. Almeida | Nancy Azevedo | A. Campar | R. Faria | A. Marinho | Esmeralda Neves | A. Tavares | E. Trombetta | B. Vigone | I. Rodríguez-Pintó | D. Belz | N. Baerlecken | M. Aguirre-Zamorano | M. Castro-Villegas | A. Escudero-Contreras | E. Raya | C. Artusi | J. Ducreux | A. Maudoux | Q. Simon | M. Alvarez | A. Dufour | Donatienne Wynar | M. Bocskai | M. Deák | G. Kádár | V. Gerl | Silvia Thiel | C. Chamberlain | J. Marovac | T. Anjos | M. Maresca | R. B. Alonso | I. Quintero | María Concepción Fernández Roldán | Yolanda Jiménez Gómez | Inmaculada Jiménez Moleón | B. Muchmore | E. Collantes | A. De Groof | N. Foulquier | D. Alvarez-Errico | R. Cervera | Michael Lehner | Alfonso Corrales Martínez | A. López‐Berrio | H. Navarro‐Linares | M. A. Riquelme | L. Le Lann | M. Alarcón-Riquelme | Nathan Foulquier | É. Bettacchioli

[1]  E. Ballestar,et al.  Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature , 2021, Scientific Reports.

[2]  D. Roccatello,et al.  Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. , 2021, Clinical and experimental rheumatology.

[3]  J. Perin,et al.  Antibodies to Both Ro52 and Ro60 for Identifying Sjögren's Syndrome Patients Best Suited for Clinical Trials of Disease‐Modifying Therapies , 2021, Arthritis care & research.

[4]  A. Morris,et al.  Genetic and clinical basis for two distinct subtypes of primary Sjögren’s syndrome , 2020, Rheumatology.

[5]  D. Courvoisier,et al.  Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers. , 2020, Rheumatology.

[6]  E. Ballestar,et al.  Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases , 2020, Arthritis & rheumatology.

[7]  E. Zampeli,et al.  Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations. , 2020, Clinical and experimental rheumatology.

[8]  Anthony R. Fehr,et al.  The impact of PARPs and ADP-ribosylation on inflammation and host–pathogen interactions , 2020, Genes & development.

[9]  Q. Qin,et al.  Identifying Key Genes and Functionally Enriched Pathways in Sjögren’s Syndrome by Weighted Gene Co-Expression Network Analysis , 2019, Front. Genet..

[10]  Claire M. Riddell,et al.  Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials , 2019, The Lancet Rheumatology.

[11]  B. Pham,et al.  Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases , 2019, Front. Immunol..

[12]  G. Natoli,et al.  PARP14 Controls the Nuclear Accumulation of a Subset of Type I IFN–Inducible Proteins , 2018, The Journal of Immunology.

[13]  A. Barabasi,et al.  PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation , 2016, Nature Communications.

[14]  J. Reed,et al.  Autoimmunity: Ro60-associated RNA takes its toll on disease pathogenesis , 2016, Nature Reviews Rheumatology.

[15]  Gene W. Yeo,et al.  The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression , 2015, Science.

[16]  A. Aggarwal.  Role of autoantibody testing. , 2014, Best practice & research. Clinical rheumatology.

[17]  Virginia Pascual,et al.  Modular Transcriptional Repertoire Analyses of Adults With Systemic Lupus Erythematosus Reveal Distinct Type I and Type II Interferon Signatures , 2014, Arthritis & rheumatology.

[18]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[19]  Oliver Distler,et al.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. , 2013, Arthritis and rheumatism.

[20]  Michael W. Jackson,et al.  Long-term Ro60 humoral autoimmunity in primary Sjögren's syndrome is maintained by rapid clonal turnover. , 2013, Clinical immunology.

[21]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[22]  R. Vierkant,et al.  Genome-wide genetic associations with IFNγ response to smallpox vaccine , 2012, Human Genetics.

[23]  G. Valesini,et al.  New autoantigens in the antiphospholipid syndrome. , 2011, Autoimmunity reviews.

[24]  P. Ravaud,et al.  EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome , 2011, Annals of the rheumatic diseases.

[25]  Witold R. Rudnicki,et al.  Feature Selection with the Boruta Package , 2010 .

[26]  Torsten Witte,et al.  Autoantibody Detection Using Indirect Immunofluorescence on HEp‐2 Cells , 2009, Annals of the New York Academy of Sciences.

[27]  G. Baron,et al.  EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome , 2009, Annals of the rheumatic diseases.

[28]  K. Ozato,et al.  Gene Disruption Study Reveals a Nonredundant Role for TRIM21/Ro52 in NF-κB-Dependent Cytokine Expression in Fibroblasts1 , 2009, The Journal of Immunology.

[29]  M. Fritzler,et al.  Latest update on the Ro/SS-A autoantibody system. , 2009, Autoimmunity reviews.

[30]  G. Kochs,et al.  Protective role of interferon-induced Mx GTPases against influenza viruses. , 2009, Revue scientifique et technique.

[31]  V. Kuchroo,et al.  Interferon-α Induces Up-regulation and Nuclear Translocation of the Ro52 Autoantigen as Detected by a Panel of Novel Ro52-specific Monoclonal Antibodies , 2008, Journal of Clinical Immunology.

[32]  Aurélia Belisova,et al.  RNA chaperone activity of protein components of human Ro RNPs. , 2005, RNA.

[33]  M. Peterson,et al.  Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. , 2005, Arthritis and rheumatism.

[34]  M. Peterson,et al.  Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus , 2004 .

[35]  D. Isenberg,et al.  The 52 000 MW Ro/SS‐A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon‐γ inducible tripartite motif protein associated with membrane proximal structures , 2002, Immunology.

[36]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[37]  T. Medsger,et al.  Criteria for the classification of early systemic sclerosis. , 2001, The Journal of rheumatology.

[38]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[39]  D. Alarcón-Segovia,et al.  Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. , 1989, The Journal of rheumatology.

[40]  J A Hardin,et al.  Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. , 1981, Science.

[41]  D. Isenberg,et al.  How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). , 2018, Clinical and experimental rheumatology.

[42]  A. Silman,et al.  Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .